everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water Solvent; Reagent/catalyst; | 88% |
With 1,1,1,3',3',3'-hexafluoro-propanol at 58℃; for 3.5h; |
everolimus
Conditions | Yield |
---|---|
With sulfuric acid In tetrahydrofuran at 0 - 10℃; for 1h; | 71% |
With sulfuric acid In tetrahydrofuran at 0 - 10℃; for 1h; Reagent/catalyst; | 3.72 g |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In water; acetone at 0 - 5℃; for 1h; | 68.3% |
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h; | 20.4 g |
With hydrogenchloride In acetone at 0 - 5℃; for 1h; | 3.58 g |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water at 5℃; pH=3 - 4; | 68% |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water at 5℃; | 67% |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water at 5℃; | 65% |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water at 5℃; | 61% |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water at 5℃; | 55% |
40-O-[2-(t-butyldimethylsilyl)oxy]ethyl rapamycin
everolimus
Conditions | Yield |
---|---|
With triethylamine tris(hydrogen fluoride) In tetrahydrofuran at 20℃; for 2h; | 54% |
With pyridine hydrogenfluoride In tetrahydrofuran at 0 - 45℃; for 1.5h; | 2.96 g |
With hydrogenchloride In methanol; water at 0 - 25℃; for 1h; pH=1-3; pH-value; Time; |
40-O-[2-(t-butyldiphenylsilyl)oxy]ethyl-rapamycin
everolimus
Conditions | Yield |
---|---|
With pyridine; hydrogen fluoride In tetrahydrofuran at 0 - 20℃; for 4h; | 15% |
With pyridine hydrogenfluoride In tetrahydrofuran at 0 - 20℃; for 4h; | 15% |
With pyridine hydrogenfluoride In tetrahydrofuran at 0 - 45℃; for 3.5h; Temperature; | 6.81 g |
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h; |
40-O-[2-((2,3-dimethylbut-2-yl)dimethylsilyloxy)ethyl] rapamycin
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water at 0℃; for 1.5h; | |
With hydrogenchloride In methanol; water at -10℃; Inert atmosphere; |
everolimus
Conditions | Yield |
---|---|
With 1,1,1,3',3',3'-hexafluoro-propanol at 50℃; for 1.5h; Reagent/catalyst; | 621 mg |
sirolimus
everolimus
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: (1-ethylpropyl)diisopropylamine / toluene / 30 °C 2: pyridine hydrogenfluoride / tetrahydrofuran / 3.5 h / 0 - 45 °C View Scheme | |
Multi-step reaction with 2 steps 1.1: 2,6-dimethylpyridine; trifluoromethylsulfonic anhydride / dichloromethane / 0.5 h / -40 °C 1.2: -40 - 40 °C 2.1: hydrogenchloride / methanol; water / 1 h / 0 - 25 °C / pH 1-3 View Scheme | |
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine / toluene / 12 h / 60 °C 2: hydrogenchloride / methanol; water / 5 °C View Scheme |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride; phosphoric acid; water In n-heptane; acetonitrile at 20℃; for 24h; | 64 %Chromat. |
31,42-bis(trimethylsilylether)rapamycin
everolimus
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: hydrogenchloride / tetrahydrofuran / 5 h / Cooling with ice 2: hydrogenchloride / toluene; water / 6 h / 0 - 10 °C 3: hydrogenchloride / water; methanol / 4.5 h / Cooling with ice View Scheme | |
Multi-step reaction with 3 steps 1: hydrogenchloride / ethyl acetate; water / Cooling with ice 2: N-ethyl-N,N-diisopropylamine / 1,2-dimethoxyethane; toluene / 4 h / 60 °C 3: hydrogenchloride / water; acetone / 1 h / 0 - 5 °C View Scheme | |
Multi-step reaction with 3 steps 1: hydrogenchloride / water / Cooling with ice 2: N-ethyl-N,N-diisopropylamine / toluene; 1,2-dimethoxyethane / 4 h / 60 °C 3: hydrogenchloride / acetone / 1 h / 0 - 5 °C View Scheme |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In methanol; water for 4.5h; Cooling with ice; | 3.8 g |
Conditions | Yield |
---|---|
With trifluorormethanesulfonic acid In toluene at 70℃; under 7500.75 Torr; for 8h; Reagent/catalyst; Temperature; Pressure; Solvent; Autoclave; | 6.9 g |
Conditions | Yield |
---|---|
Stage #1: ethylene glycol With trifluoroacetic anhydride In tetrahydrofuran at 10℃; for 1.5h; Inert atmosphere; Large scale; Stage #2: sirolimus With boron trifluoride diethyl etherate In tetrahydrofuran at 10℃; for 2h; Temperature; Large scale; | 5.7 kg |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h; |
everolimus
Conditions | Yield |
---|---|
With hydrogenchloride In water; acetonitrile at -10 - 0℃; for 0.5h; |
31-(trimethylsilylether)rapamycin
everolimus
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine / 1,2-dimethoxyethane; toluene / 4 h / 60 °C 2: hydrogenchloride / water; acetone / 1 h / 0 - 5 °C View Scheme | |
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine / toluene; 1,2-dimethoxyethane / 4 h / 60 °C 2: hydrogenchloride / acetone / 1 h / 0 - 5 °C View Scheme |
31,42-bis(triethylsilylether)rapamycin
everolimus
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: sulfuric acid / acetone / 0 - 10 °C 2: N-ethyl-N,N-diisopropylamine / toluene / 4 h / 53 °C 3: sulfuric acid / tetrahydrofuran / 1 h / 0 - 10 °C View Scheme | |
Multi-step reaction with 3 steps 1: sulfuric acid / acetone / 0 - 10 °C 2: N-ethyl-N,N-diisopropylamine / toluene; hexane / 2 h / 60 °C 3: sulfuric acid / tetrahydrofuran / 1 h / 0 - 10 °C View Scheme |
Conditions | Yield |
---|---|
Novozym 435TM lipase In tert-butyl methyl ether at 35℃; for 10h; Molecular sieve; | 96% |
at 20℃; for 4h; Enzymatic reaction; |
everolimus
42-O-(2-fluoroethyl)rapamycin
Conditions | Yield |
---|---|
With 1,3-bis(2,6-diisopropylphenyl)-2,2-difluoro-2,3-dihydro-1h-imidazole; N-ethyl-N,N-diisopropylamine In dichloromethane at 23℃; for 5h; Inert atmosphere; | 83% |
Conditions | Yield |
---|---|
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; Inert atmosphere; Darkness; | 73% |
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2.66667h; |
everolimus
(35E,37E,39E,40E,48R,49S,50R,51R,53S,55S,57S,58S,59R,60R,69R)-58-[(1R)-2-[(1S,3R,4R)-4-[2-[2-[tert-butyl(diphenyl)silyl]oxyethoxy]ethoxy]-3-methoxy-cyclohexyl]-1-methyl-ethyl]-59,69-dihydroxy-57,60-dimethoxy-48,49,50,51,61,62-hexamethyl-79,80-dioxa-71-azatricyclohexatriaconta-35,37,39(61),40(62)-tetraene-63,64,65,66,67-pentone
Conditions | Yield |
---|---|
With N-ethyl-N,N-diisopropylamine In toluene at 45℃; for 18h; | 59% |
everolimus
Conditions | Yield |
---|---|
With zinc(II) chloride In tetrahydrofuran at 60℃; for 2h; Reagent/catalyst; | 45% |
everolimus
Conditions | Yield |
---|---|
With titanium(IV) isopropylate In dichloromethane at 20℃; | 38% |
everolimus
2,2'-[1,2-ethanediylbis(oxy)]bisethanol
(21E,23E,25E,26E,36R,37S,38R,39R,41S,43S,46S,47R,48R,57R)-47,57-dihydroxy-45-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]-46-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-48-methoxy-36,37,38,39,49,50-hexamethyl-68,69-dioxa-58-azatricyclohexatriaconta-21,23,25(49),26(50)-tetraene-51,52,53,54,55-pentone
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In tetrahydrofuran; water at 20℃; for 2h; | 28% |
everolimus
diethylene glycol
(21E,23E,25E,26E,34R,35S,36R,37R,39S,41S,44S,45R,46R,55R)-45,55-dihydroxy-43-[2-(2-hydroxyethoxy)ethoxy]-44-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-46-methoxy-34,35,36,37,47,48-hexamethyl-66,67-dioxa-56-azatricyclohexatriaconta-21,23,25(47),26(48)-tetraene-49,50,51,52,53-pentone
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In tetrahydrofuran; water at 20℃; for 2h; | 19% |
Tetraethylene glycol
everolimus
(21E,23E,25E,26E,38R,39S,40R,41R,43S,45S,48S,49R,50R,59R)-49,59-dihydroxy-47-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]-48-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-50-methoxy-38,39,40,41,51,52-hexamethyl-70,71-dioxa-60-azatricyclohexatriaconta-21,23,25(51),26(52)-tetraene-53,54,55,56,57-pentone
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In tetrahydrofuran; water at 20℃; for 2h; | 17% |
heptaethylene glycol
everolimus
(21E,23E,25E,26E,44R,45S,46R,47R,49S,51S,54S,55R,56R,65R)-55,65-dihydroxy-53-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-54-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-56-methoxy-44,45,46,47,57,58-hexamethyl-76,77-dioxa-66-azatricyclohexatriaconta-21,23,25(57),26(58)-tetraene-59,60,61,62,63-pentone
Conditions | Yield |
---|---|
With toluene-4-sulfonic acid In tetrahydrofuran; water at 22℃; for 18h; Inert atmosphere; | 14% |
everolimus
Conditions | Yield |
---|---|
With triethylammonium acetate In 1,4-dioxane; water at 22 - 28℃; for 4h; |
1H-benzo[d][1,2,3]triazol-1-yl (2-(pyridin-2-yldisulfaneyl)ethyl) carbonate
everolimus
everolimus (2'-pyridyldisulfanyl)ethyl carbonate
Conditions | Yield |
---|---|
With dmap In dichloromethane for 0.5h; Inert atmosphere; |
Conditions | Yield |
---|---|
In methanol at 20℃; for 10h; |
The Everolimus is an organic compound with the formula C53H83NO14. With the CAS registry number 159351-69-6, it is also named as Certican. The product's categories are All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals. Besides, it is an off white aolid, which should be stored at temperature of -20 °C. Everolimus is used in drug-eluting coronary stents as an immunosuppressant to prevent restenosis.
Physical properties about Everolimus are: (1)ACD/LogP: 3.35; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 3.35; (4)ACD/LogD (pH 7.4): 3.35; (5)#H bond acceptors: 15; (6)#H bond donors: 3; (7)#Freely Rotating Bonds: 12; (8)Polar Surface Area: 204.66 Å2; (9)Index of Refraction: 1.548; (10)Molar Refractivity: 257.69 cm3; (11)Molar Volume: 811.2 cm3; (12)Polarizability: 102.15×10-24cm3; (13)Surface Tension: 51.3 dyne/cm; (14)Density: 1.18 g/cm3; (15)Flash Point: 557.8 °C; (16)Enthalpy of Vaporization: 165.09 kJ/mol; (17)Boiling Point: 998.7 °C at 760 mmHg.
When you are using this chemical, please be cautious about it as the following:
This chemical is danger of serious damage to health by prolonged exposure if swallowed. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).
You can still convert the following datas into molecular structure:
(1)SMILES: OCCO[C@@H]1CC[C@H](C[C@H]1OC)C[C@@H](C)[C@@H]4CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N3CCCC[C@H]3C(=O)O4
(2)InChI: InChI=1/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
(3)InChIKey: HKVAMNSJSFKALM-GKUWKFKPBE
(4)Std. InChI: InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1
(5)Std. InChIKey: HKVAMNSJSFKALM-GKUWKFKPSA-N
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View